Diane E Durecki
3PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 07, 2025
Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trial.Michael Cecchini, Mary Jo Pilat, Nataliya Uboha
|Jun 28, 2023
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors.Michael Cecchini, Zenta Walther, Wei Wei
|Mar 27, 2023
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma.Kristina Fanucci, Mary Jo Pilat, Derek Shyr
Pageof 1
Frequent Collaborators
2 joint publications
Mary Jo Pilat
2 joint publications
Derek Shyr
2 joint publications
Scott Boerner
2 joint publications
Michael Cecchini
2 joint publications
Patricia LoRusso
2 joint publications
S Percy Ivy
1 joint publications
Alice P Chen
1 joint publications
Yu Shyr
1 joint publications
Jing Li
1 joint publications
Vinay Puduvalli
